Financials data is unavailable for this security.
View more
Year on year Medifast Inc 's revenues fell -32.94% from 1.60bn to 1.07bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 143.57m to 99.42m, a -30.75% decrease.
| Gross margin | 73.80% |
|---|---|
| Net profit margin | 1.09% |
| Operating margin | 1.61% |
| Return on assets | 2.40% |
|---|---|
| Return on equity | 3.66% |
| Return on investment | 3.42% |
More ▼
Cash flow in USDView more
In 2023, Medifast Inc increased its cash reserves by 7.70%, or 6.75m. The company earned 147.66m from its operations for a Cash Flow Margin of 13.77%. In addition the company used 61.05m on investing activities and also paid 79.79m in financing cash flows.
| Cash flow per share | 1.85 |
|---|---|
| Price/Cash flow per share | 10.37 |
| Book value per share | 18.96 |
|---|---|
| Tangible book value per share | 18.96 |
More ▼
Balance sheet in USDView more
| Current ratio | 3.11 |
|---|---|
| Quick ratio | 2.55 |
| Total debt/total equity | 0.00 |
|---|---|
| Total debt/total capital | 0.00 |
More ▼
Growth rates in USD
SmartText is unavailable
| Div yield(5 year avg) | 3.59% |
|---|---|
| Div growth rate (5 year) | 17.72% |
| Payout ratio (TTM) | 2.22% |
| EPS growth(5 years) | 14.53 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -93.90 |
More ▼
